Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Effector Therapeutics Inc (NQ: EFTR ) 0.1800 UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.1800 Bid (Size) 0.1400 (3) Ask (Size) 0.1550 (11) Prev. Close 0.1800 Today's Range 0.1800 - 0.1800 52wk Range 0.1800 - 20.50 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Publicly Traded Companies Filing for Bankruptcy as July Kicks Off July 15, 2024 Explore bankruptcy risk stocks with insights on Chicken Soup for the Soul Entertainment, eFFECTOR Therapeutics, and Delta Apparel. Via InvestorPlace Topics Bankruptcy Exposures Financial Legal Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday June 26, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning! Via InvestorPlace Performance YTD -98.53% -98.53% 1 Month -84.62% -84.62% 3 Month -89.89% -89.89% 6 Month -98.25% -98.25% 1 Year -99.03% -99.03% More News Read More Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher June 24, 2024 Via Benzinga Topics Stocks Exposures US Equities Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70% June 24, 2024 Via Benzinga eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq June 24, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 28, 2024 Via Benzinga eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer May 20, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire EFTR Stock Earnings: eFFECTOR Therapeutics Meets EPS for Q1 2024 May 09, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session May 09, 2024 Via Benzinga eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire eFFECTOR Therapeutics to Participate in Upcoming Investor Conference April 09, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session April 05, 2024 Via Benzinga Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results April 04, 2024 Via Benzinga Topics Stocks Exposures US Equities Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 04, 2024 Via Benzinga Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings April 04, 2024 Via Benzinga Topics Stocks Exposures US Equities Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After Disappointing Data April 04, 2024 Via Benzinga Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000 April 04, 2024 Via Benzinga Topics Stocks Exposures US Equities eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer April 04, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday March 26, 2024 Via InvestorPlace EFTR Stock Earnings: eFFECTOR Therapeutics Misses EPS for Q4 2023 March 25, 2024 Via InvestorPlace eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 25, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session March 08, 2024 Via Benzinga eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference February 05, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules January 29, 2024 From eFFECTOR Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.